Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of BCI 838 in Healthy Adult Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01548703

Organisation Name: BrainCells Inc.

Overal Status: Completed

Start Date: February 2012

Last Update: May 9, 2012

Lead Sponsor: BrainCells Inc.

Brief Summary: This study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of BCI-838 and its metabolite BCI-632 in healthy male and female subjects.

Conditions:
  • Healthy


Total execution time in seconds: 0.20300602912903